A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD
NCT04189562 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2022-05-26
Summary
This study will assess the efficacy of the text messaging (SMS-based) disease management intervention for children with Attention Deficit/Hyperactivity Disorder (ADHD) using the timeliness of stimulant prescription renewals over a 9-month period.
Parents of participants in the study will receive customized text messages once a day, Sunday through Friday, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their child's clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.
Conditions
- Attention Deficit/Hyperactivity Disorder
Interventions
- OTHER
-
SMS Intervention
Delivery of text messages will use the text messaging program Simple Online Family Intervention for ADHD (SOFIA).
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-22
- Primary Completion
- 2023-02-28
- Completion
- 2023-06-30
Countries
- United States
Study Locations
More Related Trials
-
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
NCT00466791 ·Status: COMPLETED ·Phase: PHASE2
-
Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder
NCT00429221 ·Status: WITHDRAWN ·Phase: NA
-
Leveraging Mobile Health Technology to Optimize Early Stimulant Medication Treatment: A Feasibility Pilot
NCT01990222 ·Status: COMPLETED
-
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391 ·Status: COMPLETED ·Phase: PHASE4
-
Primary Care Prevention of Stimulant Diversion by High School Students With ADHD
NCT03080259 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
NCT00499863 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
NCT00181571 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
NCT02096952 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD
NCT01711021 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
NCT00501293 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
NCT00301236 ·Status: COMPLETED ·Phase: PHASE3
-
A Peer-Delivered High School Preparatory Intervention for Students With ADHD
NCT04571320 ·Status: COMPLETED ·Phase: NA
-
AWARE: Management of ADHD in Autism Spectrum Disorder
NCT05916339 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder
NCT01583829 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
NCT05286762 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
NCT03325881 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01259492 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD
NCT00506285 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
NCT01239030 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
NCT00151983 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate for Treating Children With ADHD and Tourette Syndrome
NCT00441649 ·Status: COMPLETED ·Phase: NA
-
Methylphenidate in Healthy Young Adults
NCT00815841 ·Status: UNKNOWN ·Phase: PHASE4
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT00050622 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
NCT00428792 ·Status: COMPLETED ·Phase: PHASE3
-
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
NCT00824317 ·Status: COMPLETED ·Phase: NA